Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway

Introduction and aim. Hepatocyte growth factor (HGF) has been shown to ameliorate liver inflammation and fibrosis; however, the mechanism underlying its effects in non-alcoholic steatohepatitis (NASH) is unclear. This study aimed to analyse the relationship between the JAK2-STAT3 signalling pathway...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ning Li, Zhangfeng Dou, Jinchun Liu, Bao Chai, Yue Li, Xiuqin An, Peiling Chu, Xiaolan Zhang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2018-05-01
Schriftenreihe:	Annals of Hepatology
Schlagworte:	Non-alcoholic steatohepatitis Hepatocyte growth factor HGF/c-Met JAK2-STAT3 signalling pathway
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1665268119302066
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!